| Literature DB >> 31242408 |
Chia-Hsuan Fu1, Daniel Maxim Iascone2, Iraklis Petrof1, Anupam Hazra2, Xiaohong Zhang2, Mark S Pyfer2, Umberto Tosi2, Brian F Corbett2, Jingli Cai2, Jason Lee3, Jin Park3, Lorraine Iacovitti2, Helen E Scharfman4, Grigori Enikolopov5, Jeannie Chin6.
Abstract
Adult hippocampal neurogenesis has been reported to be decreased, increased, or not changed in Alzheimer's disease (AD) patients and related transgenic mouse models. These disparate findings may relate to differences in disease stage, or the presence of seizures, which are associated with AD and can stimulate neurogenesis. In this study, we investigate a transgenic mouse model of AD that exhibits seizures similarly to AD patients and find that neurogenesis is increased in early stages of disease, as spontaneous seizures became evident, but is decreased below control levels as seizures recur. Treatment with the antiseizure drug levetiracetam restores neurogenesis and improves performance in a neurogenesis-associated spatial discrimination task. Our results suggest that seizures stimulate, and later accelerate the depletion of, the hippocampal neural stem cell pool. These results have implications for AD as well as any disorder accompanied by recurrent seizures, such as epilepsy.Entities:
Keywords: Alzheimer; cognition; dentate gyrus; epilepsy; hippocampus; memory; mouse model; neural stem cell pool; neurogenesis; seizure
Mesh:
Year: 2019 PMID: 31242408 PMCID: PMC6697001 DOI: 10.1016/j.celrep.2019.05.101
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423